Bloomington, Ind. – Beginning January 1, 2012, Cook Medical’s central venous catheters (CVCs) will be available to the members served by Novation, the supply contracting company for more than 30,000 members of VHA Inc., UHC, and Provista. This expands nationwide access to these devices through one of industry’s leading health care supply contracting companies.
The contract includes access to Cook’s comprehensive CVC product offering, including Spectrum® minocycline and rifampin impregnated catheters.
“We are pleased that our relationship with Novation continues to grow as we add another business division to its distribution network,” said Dan Sirota, vice president and business unit leader of Cook Medical’s Critical Care and Interventional Radiology divisions. “Our Spectrum central venous catheter sets have been shown to minimize the risk of catheter-related bloodstream infections (CRBSIs). Cook is proud to partner with Novation in delivering a technology that helps prevent dangerous and potentially fatal infections and reduces health care costs to its expansive network of health care providers.”
An estimated 78,000 patients are infected with CRBSIs in the U.S. annually with an average cost estimated at $16,550 to treat per infection.¹ Two decades of evidence, including more than 21 peer-reviewed studies and meta-analyses, confirm that minocycline and rifampin catheters are the most effective tool available to prevent CRBSIs. In addition, Spectrum CVCs meet the newly released recommendations from the CDC for reducing CRBSI if maximal sterile barrier precautions haven’t helped a facility reach its goal.²
Founded in 1998, Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and UHC, two national health care alliances, and 5,500 members of Provista, LLC, representing more than 30,000 sites. Novation provides alliance members sourcing and information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase approximately $40 billion in 2010.
About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologic grafts to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter @cookmedicalpr and @cookcriticalcre.
¹ Department of Health & Human Services, Vital Signs: Central Line-Associated Blood Stream Infections – United States, 2001, 2008, and 2009: 2011. Washington, DC: Centers for Disease Control
² O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4 suppl 1):S1-S34.